Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

Part of paid clinical trials in Downey, California.

Sponsor
EG 427
Study ID
NCT06596291
Phase
PHASE1/PHASE2
Status
Recruiting

Conditions

  • Neurogenic Detrusor Overactivity
  • Spinal Cord Injuries

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • EG110A — DRUG
    Participants treated with EG110A

Study Details

This is a first-in-human, Phase 1b/2a, open-label, dose-escalation study of a single treatment course consisting of multiple intradetrusor injections of EG110A in male and female adult participants with Neurogenic Detrusor Overactivity (NDO)-related incontinence following Spinal Cord Injury (SCI), who have persistent incontinence after standard of care therapy and who perform Clear Intermittent Catheterization (CIC) on a regular basis.

Key Dates

Start date
Jan 8, 2025
Status verified
Feb 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
16 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: EG110A (low dose)
    Patients who Received EG110A (low dose)
  • Experimental: EG110A (Middle Dose)
    Patients who Received EG110A (middle dose)
  • Experimental: EG110A (High Dose)
    Patients who Received EG110A (high dose)

Primary Outcome Measure

Incidence of treatment-emergent adverse events (TEAEs) [ Time Frame: 1 year ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Rancho Los Amigos National Rehabilitation CenterDowneyCalifornia90242
Evgeniy Kreydin, MD
University of Michigan Rogel Cancer CenterAnn ArborMichigan48109-
Sidney Kimmel Medical CollegePhiladelphiaPennsylvania19107
Patrick Shenot, MD
UTHealth Houston / TIRR Memorial HermannHoustonTexas77030
Argyrios Stampas, MD

Find similar trials in Downey, CA

Related Studies